Publications

Anke E. Kip, Séverine Blesson, Fabiana Alves, Monique Wasunna, Robert Kimutai, Peninah Menza, Bewketu Mengesha, Jos H. Beijnen, Asrat Hailu, Ermias Diro, Thomas P. C. Dorlo . Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: an Ethiopian cohort study. Journal of Antimicrobial Chemotherapy, 2021.

Luka Verrest, Anke E. Kip, Ahmed M. Musa, Gerard J. Schoone, Henk D. F. H. Schallig, Jane Mbui, Eltahir A. G. Khalil, Brima M. Younis, Joseph Olobo, Lilian Were, Robert Kimutai, Séverine Monnerat, Isra Cruz, Monique Wasunna, Fabiana Alves, Thomas P. C. Dorlo . Blood parasite load as an early marker to predict treatment response in visceral leishmaniasis in Eastern Africa. Clinical Infectious Diseases, 2021.

Maarten van Eijk, Dick Pluim, Thomas P. C. Dorlo, Serena Marchetti, Alwin D. R. Huitema, Jos H. Beijnen . Investigating the influence of relevant pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of orally administered docetaxel combined with ritonavir. Pharmacogenomics Journal, 2021.

Julie M. Janssen, Kristel Van Calsteren, Thomas P. C. Dorlo, Michael J. Halaska, Robert Fruscio, Petronella Ottevanger, Carolien P. Schröder, Ingrid Boere, Petronella O. Witteveen, Rebecca C. Painter, Ruud Bekkers, Vit Drochytek, Jos H. Beijnen, Alwin D. R. Huitema, Frederic C. H. Amant . Population Pharmacokinetics of Docetaxel, Paclitaxel, Doxorubicin and Epirubicin in Pregnant Women with Cancer: A Study from the International Network of Cancer, Infertility and Pregnancy (INCIP). Clinical Pharmacokinetics, 2021.

Julie M. Janssen, Bart A. W. Jacobs, Jeroen Roosendaal, Ellen J. B. Derissen, Serena Marchetti, Jos H. Beijnen, Alwin D. R. Huitema, Thomas P. C. Dorlo . Population Pharmacokinetics of Intracellular 5-Fluorouridine 5'-Triphosphate and its Relationship with Hand-and-Foot Syndrome in Patients Treated with Capecitabine. The AAPS Journal, 2021.

Semra Palić, Anke E. Kip, Jos H. Beijnen, Jane Mbui, Ahmed Musa, Alexandra Solomos, Monique Wasunna, Joseph Olobo, Fabiana Alves, Thomas P. C. Dorlo . Characterizing the non-linear pharmacokinetics of miltefosine in paediatric visceral leishmaniasis patients from Eastern Africa. Journal of Antimicrobial Chemotherapy, 2020.

Huixin Yu, Julie M. Janssen, Vincent A. de Weger, Bastiaan Nuijen, Rik E. Stuurman, Serena Marchetti, Jan H. M. Schellens, Jos H. Beijnen, Thomas P. C. Dorlo, Alwin D. R. Huitema . Quantification of the pharmacokinetic-toxicodynamic relationship of oral docetaxel co-administered with ritonavir. Investigational New Drugs, 2020.

Keith T. Schmidt, Alwin D. R. Huitema, Thomas P. C. Dorlo, Cody J. Peer, Lisa M. Cordes, Linda Sciuto, Susan Wroblewski, Yves Pommier, Ravi A. Madan, Anish Thomas, William D. Figg . Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors. Cancer Chemotherapy and Pharmacology, 2020.

Ignace C. Roseboom, Hilde Rosing, Jos Beijnen, Thomas P. C. Dorlo . Skin tissue sample collection, sample homogenization, and analyte extraction strategies for liquid chromatographic mass spectrometry quantification of pharmaceutical compounds. Journal of Pharmaceutical and Biomedical Analysis, 2020.

Julie M. Janssen, Thomas P. C. Dorlo, Jos H. Beijnen, Alwin D. R. Huitema . Evaluation of Extrapolation Methods to Predict Trough Concentrations to Guide Therapeutic Drug Monitoring of Oral Anticancer Drugs. Therapeutic Drug Monitoring, 2020.

Ignace C. Roseboom, Bas Thijssen, Hilde Rosing, Jane Mbui, Jos Beijnen, Thomas P. C. Dorlo . Highly Sensitive UPLC-MS/MS Method for the Quantification of Paromomycin in Human Plasma. Journal of Pharmaceutical and Biomedical Analysis, 2020.

Julie M. Janssen, Thomas P.C. Dorlo, Neeltje Steeghs, Jos H. Beijnen, Lidwien M. Hanff, Natasha K.A. van Eijkelenburg, Jasper van der Lugt, C. Michel Zwaan, Alwin D.R. Huitema . Pharmacokinetic Targets for Therapeutic Drug Monitoring of Small Molecule Kinase Inhibitors in Pediatric Oncology. Clinical Pharmacology & Therapeutics, 2020.

Aurelia H. M. de Vries Schultink, Kees Bol, Robert P. Doornbos, Anastasia Murat, Ernesto Wasserman, Thomas P. C. Dorlo, Jan H. M. Schellens, Jos H. Beijnen, Alwin D. R. Huitema . Population Pharmacokinetics of MCLA-128, a HER2/HER3 Bispecific Monoclonal Antibody, in Patients With Solid Tumors. Clinical Pharmacokinetics, 2020.

Jurgen B. Langenhorst, Thomas P. C. Dorlo, Charlotte van Kesteren, Erik M. van Maarseveen, Stefan Nierkens, Moniek A. de Witte, Jaap Jan Boelens, Alwin D. R. Huitema . Clinical Trial Simulation to Optimize Trial Design for Fludarabine Dosing Strategies in Allogeneic Hematopoietic Cell Transplantation. CPT Pharmacometrics & Systems Pharmacology, 2020.

Marie-Rose B. S. Crombag, Thomas P. C. Dorlo, Ellen van der Pan, Anouk van Straten, Andries M. Bergman, Nielka P. van Erp, Jos H. Beijnen, Alwin D. R. Huitema . Exposure to Docetaxel in the Elderly Patient Population: A Population Pharmacokinetic Study. Pharmaceutical Research, 2019.

Marie-Rose B. S. Crombag, Stijn L. W. Koolen, Sophie Wijngaard, Markus Joerger, Thomas P. C. Dorlo, Nielka P. van Erp, Ron H. J. Mathijssen, Jos H. Beijnen, Alwin D. R. Huitema . Does Older Age Lead to Higher Risk for Neutropenia in Patients Treated with Paclitaxel?. Pharmaceutical Research, 2019.

Cees N. M. Renckens, Thomas P. C. Dorlo . Quackery at WHO: A Chinese Affair. Skeptical Inquirer, 2019.

Jurgen B. Langenhorst, Charlotte van Kesteren, Erik M. van Maarseveen, Thomas P. C. Dorlo, Stefan Nierkens, Moniek A. de Witte, Anna van Rhenen, Reinier Raijmakers, Marc Bierings, Jürgen Kuball, Alwin D. R. Huitema, Jaap Jan Boelens . Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes. Blood Advances, 2019.

Julie M. Janssen, Thomas P.C. Dorlo, D. Niewerth, C. Michel Zwaan, Jos H. Beijnen, A. Attarbashi, A. Baruchel, F. Fagioli, B. de Moerloose, G. Palumbo, G.J.L. Kaspers, Alwin D.R. Huitema . A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. Clinical Pharmacokinetics, 2019.

Semra Palić, Patrick Bhairosing, Jos H. Beijnen, Thomas P.C. Dorlo . Systematic review of host-mediated activity of miltefosine in leishmaniasis through immunomodulation. Antimicrobial Agents and Chemotherapy, 2019.

Jurgen B. Langenhorst, Thomas P. C. Dorlo, Erik M. van Maarseveen, Stefan Nierkens, Jürgen Kuball, Jaap Jan Boelens, Charlotte van Kesteren, Alwin D. R. Huitema . Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation. Clinical Pharmacokinetics, 2019.

Jane Mbui, Joseph Olobo, Raymond Omollo, Alexandra Solomos, Anke E. Kip, George Kirigi, Patrick Sagaki, Robert Kimutai, Lilian Were, Truphosa Omollo, Thaddaeus W. Egondi, Monique Wasunna, Jorge Alvar, Thomas P. C. Dorlo, Fabiana Alves . Pharmacokinetics, safety and efficacy of an allometric miltefosine regimen for the treatment of visceral leishmaniasis in Eastern African children: an open-label, phase-II clinical trial. Clinical Infectious Diseases, 2019.

Cees N. M. Renckens, Thomas P. C. Dorlo . Hoe China de WHO misbruikt voor zijn eigen agenda. Medisch Contact, 2019.

Marie-Rose B. S. Crombag, Aurelia H. M. de Vries Schultink, Stijn L. W. Koolen, Sophie Wijngaard, Markus Joerger, Jan H. M. Schellens, Thomas P. C. Dorlo, Nielka P. van Erp, Ron H. J. Mathijssen, Jos H. Beijnen, Alwin D. R. Huitema . Impact of Older Age on the Exposure of Paclitaxel: a Population Pharmacokinetic Study. Pharmaceutical Research, 2019.

Dziedzom K. de Souza, Thomas P. C. Dorlo . Safe mass drug administration for neglected tropical diseases. The Lancet Global Health, 2018.

Jesmin Lohy Das, Stephen Rulisa, Peter J. de Vries, Petra F. Mens, Nadine Kaligirwa, Steven Agaba, Joel Tarning, Mats O. Karlsson, Thomas P. C. Dorlo . Population Pharmacokinetics of Artemether, Dihydroartemisinin, and Lumefantrine in Rwandese Pregnant Women Treated for Uncomplicated Plasmodium falciparum Malaria. Antimicrobial Agents and Chemotherapy, 2018.

Anke E. Kip, María Del Mar Castro, Maria Adelaida Gomez, Alexandra Cossio, Jan H. M. Schellens, Jos H. Beijnen, Nancy Gore Saravia, Thomas P. C. Dorlo . Simultaneous population pharmacokinetic modelling of plasma and intracellular PBMC miltefosine concentrations in New World cutaneous leishmaniasis and exploration of exposure-response relationships. Journal of Antimicrobial Chemotherapy, 2018.

Aurelia H. M. de Vries Schultink, Annelies H. Boekhout, Jourik A. Gietema, Artur M. Burylo, Thomas P. C. Dorlo, J. G. Coen van Hasselt, Jan H. M. Schellens, Alwin D. R. Huitema . Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens. Journal of Pharmacokinetics and Pharmacodynamics, 2018.

Anke E. Kip, Monique Wasunna, Fabiana Alves, Jan H. M. Schellens, Jos H. Beijnen, Ahmed M. Musa, Eltahir A. G. Khalil, Thomas P. C. Dorlo . Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis. Frontiers in Cellular and Infection Microbiology, 2018.

Fabiana Alves, Jean-Yves Gillon, Byron Arana, Thomas P. C. Dorlo . From Bench to Bedside: Development and Optimization of Clinical Therapies for Visceral Leishmaniasis. In: Drug Discovery for Leishmaniasis, The Royal Society of Chemistry, pp. 37–54, 2018.

Anke E. Kip, Jan H. M. Schellens, Jos H. Beijnen, Thomas P. C. Dorlo . Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs. Clinical Pharmacokinetics, 2018.

Thomas P. C. Dorlo, Anke E. Kip, Brima M. Younis, Sally J. Ellis, Fabiana Alves, Jos H. Beijnen, Simon Njenga, George Kirigi, Asrat Hailu, Joseph Olobo, Ahmed M. Musa, Manica Balasegaram, Monique Wasunna, Mats O. Karlsson, Eltahir A. G. Khalil . Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study. Journal of Antimicrobial Chemotherapy, 2017.

A. E. Kip, K. C. Kiers, H. Rosing, J. H. M. Schellens, J. H. Beijnen, T. P. C. Dorlo . Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samples. Journal of Pharmaceutical and Biomedical Analysis, 2017.

María Del Mar Castro, Maria Adelaida Gomez, Anke E. Kip, Alexandra Cossio, Eduardo Ortiz, Adriana Navas, Thomas P. C. Dorlo, Nancy Gore Saravia . Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis. Antimicrobial Agents and Chemotherapy, 2017.

Thomas P. C. Dorlo . Letter by Dorlo Regarding Article, "Acupuncture Therapy and Incidence of Depression After Stroke". Stroke, 2017.

Luka Verrest, Thomas P. C. Dorlo . Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: A Systematic Review. Clinical Pharmacokinetics, 2017.

Wim Adriaensen, Thomas P. C. Dorlo, Guido Vanham, Luc Kestens, Paul M. Kaye, Johan van Griensven . Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients. Frontiers in Immunology, 2017.

Nicole van der Zouwe, Frits van Dam, Thomas P. C. Dorlo . Gebruik van niet-reguliere behandelwijzen voor kanker naast reguliere behandeling. In: Leerboek Oncologie, Bohn Stafleu van Loghum, 2017.

Luuk C. T. Dohmen, Adriana Navas, Deninson Alejandro Vargas, David J. Gregory, Anke Kip, Thomas P. C. Dorlo, Maria Adelaida Gomez . Functional Validation of ABCA3 as a Miltefosine Transporter in Human Macrophages: IMPACT ON INTRACELLULAR SURVIVAL OF LEISHMANIA (VIANNIA) PANAMENSIS. Journal of Biological Chemistry, 2016.

A. E. Kip, H. Rosing, M. J. X. Hillebrand, S. Blesson, B. Mengesha, E. Diro, A. Hailu, J. H. M. Schellens, J. H. Beijnen, T. P. C. Dorlo . Validation and Clinical Evaluation of a Novel Method To Measure Miltefosine in Leishmaniasis Patients Using Dried Blood Spot Sample Collection. Antimicrobial Agents and Chemotherapy, 2016.

Thomas P. C. Dorlo, Bart A. Ostyn, Surendra Uranw, Jean-Claude Dujardin, Marleen Boelaert . Treatment of visceral leishmaniasis: pitfalls and stewardship. The Lancet Infectious Diseases, 2016.

Raffaella Ravinetto, Anja De Weggheleire, Thomas P. C. Dorlo, Sven Francque, An Sokkab, Corinne Pouget, Bruno Meessen, Patricia Tabernero, Paul N. Newton, Lut Lynen . Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint. Tropical Medicine & International Health:, 2016.

Thomas P. C. Dorlo, Carmen FernA�ndez, Marita Troye-Blomberg, Peter J. de Vries, Diana Boraschi, Wilfred F. Mbacham . Poverty-Related Diseases College: a virtual African-European network to build research capacity. BMJ Global Health, 2016.

Anny Fortin, Thomas P. C. Dorlo, Sarah Hendrickx, Louis Maes . Pharmacokinetics and pharmacodynamics of oleylphosphocholine in a hamster model of visceral leishmaniasis. Journal of Antimicrobial Chemotherapy, 2016.

Monique Wasunna, Simon Njenga, Manica Balasegaram, Neal Alexander, Raymond Omollo, Tansy Edwards, Thomas P. C. Dorlo, Brima Musa, Mohammed Hassan Sharaf Ali, Mohammed Yasein Elamin, George Kirigi, Rashid Juma, Anke E. Kip, Gerard J. Schoone, Asrat Hailu, Joseph Olobo, Sally Ellis, Robert Kimutai, Susan Wells, Eltahir Awad Gasim Khalil, Nathalie Strub Wourgaft, Fabiana Alves, Ahmed Musa . Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial. PLOS Neglected Tropical Diseases, 2016.

Lisa C. Martial, Roger J. M. Brüggemann, Jeroen A. Schouten, Henk J. van Leeuwen, Arthur R. van Zanten, Dylan W. de Lange, Eline W. Muilwijk, Paul E. Verweij, David M. Burger, Rob E. Aarnoutse, Peter Pickkers, Thomas P. C. Dorlo . Dose Reduction of Caspofungin in Intensive Care Unit Patients with Child Pugh B Will Result in Suboptimal Exposure. Clinical Pharmacokinetics, 2016.

Sharon L. Roy, Jane T. Atkins, Rosemaria Gennuso, Danny Kofos, Rama R. Sriram, Thomas P. C. Dorlo, Teresa Hayes, Yvonne Qvarnstrom, Zuzana Kucerova, B. Joseph Guglielmo, Govinda S. Visvesvara . Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain. Parasitology Research, 2015.

A. E. Kip, H. Rosing, M. J. X. Hillebrand, M. M. Castro, M. A. Gomez, J. H. M. Schellens, J. H. Beijnen, T. P. C. Dorlo . Quantification of miltefosine in peripheral blood mononuclear cells by high-performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 2015.

A. R. Kreeftmeijer-Vegter, T. P. C. Dorlo, M. P. Gruppen, A. de Boer, P. J. de Vries . Population pharmacokinetics of levamisole in children with steroid-sensitive nephrotic syndrome. British Journal of Clinical Pharmacology, 2015.

Thomas P. C. Dorlo, Wim Betz, Cees N. M. Renckens . WHO's Strategy on Traditional and Complementary Medicine. Scientific Inquirer, 2015.

Anke E. Kip, Manica Balasegaram, Jos H. Beijnen, Jan H. M. Schellens, Peter J. de Vries, Thomas P. C. Dorlo . Systematic review of biomarkers to monitor therapeutic response in leishmaniasis. Antimicrobial Agents and Chemotherapy, 2015.

Thomas P. C. Dorlo, Manica Balasegaram . Different liposomal amphotericin B formulations for visceral leishmaniasis. The Lancet Global Health, 2014.

Thomas P. C. Dorlo, Suman Rijal, Bart Ostyn, Peter J. de Vries, Rupa Singh, Narayan Bhattarai, Surendra Uranw, Jean-Claude Dujardin, Marleen Boelaert, Jos H. Beijnen, Alwin D. R. Huitema . Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure. Journal of Infectious Diseases, 2014.

Johannes Blum, Pierre Buffet, Leo Visser, Gundel Harms, Mark S. Bailey, Eric Caumes, Jan Clerinx, Pieter P. A. M. van Thiel, Gloria Morizot, Christoph Hatz, Thomas P. C. Dorlo, Diana N. J. Lockwood . LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014. Journal of Travel Medicine, 2014.

Eltahir A. G. Khalil, Teklu Weldegebreal, Brima M. Younis, Raymond Omollo, Ahmed M. Musa, Workagegnehu Hailu, Abuzaid A. Abuzaid, Thomas P. C. Dorlo, Zewdu Hurissa, Sisay Yifru, William Haleke, Peter G. Smith, Sally Ellis, Manica Balasegaram, Ahmed M. EL-Hassan, Gerard J. Schoone, Monique Wasunna, Robert Kimutai, Tansy Edwards, Asrat Hailu . Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial. PLOS Neglected Tropical Diseases, 2014.

Bart Ostyn, Epco Hasker, Thomas P. C. Dorlo, Suman Rijal, Shyam Sundar, Jean-Claude Dujardin, Marleen Boelaert . Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia. PloS One, 2014.

Thomas P. C. Dorlo, Bart A. Ostyn, Jos H. Beijnen, Marleen Boelaert, Jean-Claude Dujardin, Suman Rijal . Reply to Arya and Agarwal. Clinical Infectious Diseases, 2013.

Raffaella M. Ravinetto, Thomas P. C. Dorlo, Jean-Michel Caudron, N. S. Prashanth . The global impact of Indian generics on access to health. Indian Journal of Medical Ethics, 2013.

Suman Rijal, Bart Ostyn, Surendra Uranw, Keshav Rai, Narayan Raj Bhattarai, Thomas P. C. Dorlo, Jos H. Beijnen, Manu Vanaerschot, Saskia Decuypere, Subodh S. Dhakal, Murari Lal Das, Prahlad Karki, Rupa Singh, Marleen Boelaert, Jean-Claude Dujardin . Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clinical Infectious Diseases, 2013.

Cees N. M. Renckens, Thomas P. C. Dorlo . Please, let not Western quackery replace traditional medicine in Africa. Tropical Medicine & International Health:, 2013.

Surendra Uranw, Bart Ostyn, Thomas P. C. Dorlo, Epco Hasker, Bruno Dujardin, Jean-Claude Dujardin, Suman Rijal, Marleen Boelaert . Adherence to miltefosine treatment for visceral leishmaniasis under routine conditions in Nepal. Tropical Medicine & International Health:, 2013.

Thomas P. C. Dorlo, Nynke G. L. Jager, Jos H. Beijnen, Jan H. M. Schellens . [Concomitant use of proton pump inhibitors and systemic corticosteroids]. Nederlands Tijdschrift Voor Geneeskunde, 2013.

Thomas P. C. Dorlo, Raffaella M. Ravinetto, Jos H. Beijnen, Marleen Boelaert . Commentary: Substandard medicines are the priority for neglected tropical diseases. BMJ, 2012.

Thomas P. C. Dorlo, Marleen Boelaert, Jos H. Beijnen, Raffaella Ravinetto . Universal access to quality medicines: prioritisation of a-priori solutions. The Lancet Infectious Diseases, 2012.

Thomas P. C. Dorlo, Manica Balasegaram, Jos H. Beijnen, Peter J. de Vries . Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. Journal of Antimicrobial Chemotherapy, 2012.

Thomas P. C. Dorlo, Manica Balasegaram, María Angeles Lima, Peter J. de Vries, Jos H. Beijnen, Alwin D. R. Huitema . Translational pharmacokinetic modelling and simulation for the assessment of duration of contraceptive use after treatment with miltefosine. Journal of Antimicrobial Chemotherapy, 2012.

Thomas P. C. Dorlo, Alwin D. R. Huitema, Jos H. Beijnen, Peter J. de Vries . Optimal dosing of miltefosine in children and adults with visceral leishmaniasis. Antimicrobial Agents and Chemotherapy, 2012.

Pauline Byakika-Kibwika, Mohammed Lamorde, Violet Okaba-Kayom, Harriet Mayanja-Kizza, Elly Katabira, Warunee Hanpithakpong, Nadine Pakker, Thomas P. C. Dorlo, Joel Tarning, Niklas Lindegardh, Peter J. de Vries, David Back, Saye Khoo, Concepta Merry . Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults. Journal of Antimicrobial Chemotherapy, 2012.

Thomas P. C. Dorlo, Teunis A. Eggelte, Peter J. de Vries, Jos H. Beijnen . Characterization and identification of suspected counterfeit miltefosine capsules. The Analyst, 2012.

Thomas P. C. Dorlo, Teunis A. Eggelte, Gerard J. Schoone, Peter J. de Vries, Jos H. Beijnen . A poor-quality generic drug for the treatment of visceral leishmaniasis: a case report and appeal. PLOS Neglected Tropical Diseases, 2012.

Thomas P. C. Dorlo, Pieter P. A. M. van Thiel, Gerard J. Schoone, Ymkje Stienstra, MichA�le van Vugt, Jos H. Beijnen, Peter J. de Vries . Dynamics of parasite clearance in cutaneous leishmaniasis patients treated with miltefosine. PLOS Neglected Tropical Diseases, 2011.

Raymond Omollo, Neal Alexander, Tansy Edwards, Eltahir A. G. Khalil, Brima M. Younis, Abuzaid A. Abuzaid, Monique Wasunna, Njenga Njoroge, Dedan Kinoti, George Kirigi, Thomas P. C. Dorlo, Sally Ellis, Manica Balasegaram, Ahmed M. Musa . Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial. Trials, 2011.

Dieta Brandsma, Thomas P. C. Dorlo, John H. Haanen, Jos H. Beijnen, Willem Boogerd . Severe encephalopathy and polyneuropathy induced by dichloroacetate. Journal of Neurology, 2010.

Thomas P. C. Dorlo, Piet A. Kager . Comment on: Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2010.

Thomas P. C. Dorlo, Henk Timmerman . China vaart wel bij kruidenexport. Medisch Contact, 2009.

Thomas P. C. Dorlo, Pieter P. A. M. van Thiel, Alwin D. R. Huitema, Ron J. Keizer, Henry J. C. de Vries, Jos H. Beijnen, Peter J. de Vries . Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients. Antimicrobial Agents and Chemotherapy, 2008.

Thomas P. C. Dorlo, Piet A. Kager . Pentamidine dosage: a base/salt confusion. PLOS Neglected Tropical Diseases, 2008.

Thomas P. C. Dorlo, Michel J. X. Hillebrand, Hilde Rosing, Teunis A. Eggelte, Peter J. de Vries, Jos H. Beijnen . Development and validation of a quantitative assay for the measurement of miltefosine in human plasma by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, 2008.

T. P. C. Dorlo, T. A. Eggelte, J. H. Beijnen, P. J. de Vries . [Miltefosine: a new remedy for leishmaniasis]. Nederlands Tijdschrift Voor Geneeskunde, 2006.